InDevR同圣犹大儿童研究医院合作开发新型流感检测技术

  近日，InDevR公司宣布同圣犹大儿童研究医院研究者Richard Webby的实验室合作开发新型的流感诊断测试技术。
  Richard Webby表示，这或将帮助位于科罗拉多州博尔德市的公司开发新型的FluChip-8G检测技术，这种测试技术是一种基于微阵列的临床测试，主要用于对流感病毒进行基因分型。早在一年前InDevR公司已经同生物医药前沿公司签署了一项价值1470万的合同用于完成该项测试。
  研究者Webby是一位进行流感研究的专家，而且他还是世界卫生组织动物和鸟类流感研究中心的主人，他表示，我们实验室后期将进行更多研究来评估FluChip-8G对非季节性禽流感病毒的检测效力。
  如果该检测技术被美国FDA批准，那么其或将帮助医生们对季节性和潜在的非流行性的流感病毒比如H5N1和H7N9进行快速地区分。（转化医学网360zhyx.com）
  以上为转化医学网原创翻译整理，转载请注明出处和链接！
转化医学网推荐的新闻阅读：

InDevR, St. Jude Collaborate to Evaluate Influenza Test
InDevR this week announced a collaboration with St. Jude Children's Research Hospital's Richard Webby on the development of a diagnostic test for influenza. 

Webby's laboratory will help the Boulder, Colorado-based firm develop its FluChip-8G, a microarray-based clinical test for genotyping influenza viruses. InDevR signed a $14.7 million contract with the Biomedical Advanced Research and Development Authority about a year ago to finish developing the test.

Webby is an expert on influenza and director of the World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds at St. Jude. As part of its collaboration with InDevR, Webby's lab will evaluate the performance of FluChip-8G on non-seasonal influenza viruses. 

If cleared by the US Food and Drug Administration, FluChip-8G will enable physicians to rapidly distinguish between seasonal and potential pandemic non-season influenza viruses such as H5N1 and H7N9, InDevR said.